ETT-500 Pharmaqo

£128.00

ETT-500 Pharmaqo is a trenbolone enanthate-based research formulation designed for in-vitro laboratory studies examining long-ester anabolic compound properties and receptor binding mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
ETT-500 Pharmaqo
ETT-500 Pharmaqo
£128.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About ETT-500 Pharmaqo

ETT-500 Pharmaqo is a trenbolone enanthate-based research formulation developed for in-vitro laboratory investigations. This long-ester anabolic compound enables researchers to examine sustained receptor binding mechanisms and tissue-selective androgenic activity in controlled laboratory environments. The enanthate ester modification provides extended stability characteristics ideal for protracted experimental protocols. Our Stroid UK Shop maintains strict quality standards for all investigational compounds used in academic and commercial laboratory settings.

Laboratory Research Applications

Researchers investigate ETT-500 for its distinctive molecular properties in androgenic receptor binding studies. The compound’s enhanced anabolic-to-androgenic ratio makes it valuable for examining tissue-specific receptor activation pathways and nitrogen retention mechanisms in cell culture models. Scientists studying muscle protein synthesis pathways utilise this formulation to analyse mammalian target of rapamycin (mTOR) signalling cascades. Comparative studies with other compounds from our trenbolone enanthate collection provide insights into ester chain length effects on bioavailability parameters. Research teams examining glucocorticoid receptor antagonism properties incorporate this compound into multi-factorial experimental designs. The formulation’s stability characteristics support long-term storage requirements for extensive research protocols. Investigators studying feed efficiency mechanisms in animal models utilise ETT-500 to examine metabolic pathway modifications. Additionally, researchers exploring alternative therapeutic approaches compare this compound with emerging SARM compounds to evaluate distinct receptor selectivity profiles. Comparative analysis with peptide-based modulators offers insights into different mechanisms of anabolic signalling activation.

Technical Specifications

ETT-500 Pharmaqo Laboratory Specifications
Parameter Specification
Active Compound Trenbolone Enanthate
Concentration 500mg/mL
Manufacturer Pharmaqo
Form Injectable Solution
Storage Requirements Room Temperature, Protected from Light
Research Grade Laboratory Standard
Molecular Formula Verify with supplier
CAS Number Verify with supplier

Regulatory Compliance

ETT-500 Pharmaqo is manufactured exclusively for in-vitro laboratory research applications. This compound is not intended for human consumption, therapeutic use, or veterinary applications. Researchers must ensure compliance with all applicable laboratory safety protocols and institutional research guidelines. All experimental work should be conducted in appropriately licensed facilities with proper waste disposal procedures. This product is restricted to qualified research institutions and licensed laboratories conducting legitimate scientific investigations.

Related